Delivery Order SPE2DB24D1107-SPE2DB25FZFW8
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Levorphanol Tablets 2mg, valued at $3,879.10 under a firm fixed-price contract. This is a non-set-aside award issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $3,071.22 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) under a firm fixed-price contract. The delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Levorphanol Tablets 2mg with a ceiling value of $10,969.48 and a completion date of September 30, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,782.46 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location for this pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Levorphanol Tablets 2mg, a controlled pharmaceutical product used in pain management. This firm fixed-price delivery order, valued at $8,422.31, was awarded without set-aside designation through competitive procurement and is scheduled for completion by June 25, 2025. The place of performance is AmerisourceBergen's corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,968.86 firm fixed-price delivery order is for the supply of 4564803696 units of Levorphanol 2 mg tablets, with a period of performance through May 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $3,071.22 fixed-price delivery order is for the supply of 100 tablets of the medication Levorphanol 2 mg. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $5,554.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561399691 Levorphanol tabs 2mg. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products from its facility located in Conshohocken, Pennsylvania. The delivery order was awarded on July 3, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZFW8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering medications across multiple therapeutic domains, including specialty pharmaceuticals, vaccines, and medical supplies. The current delivery order for Levorphanol, a narcotic analgesic used for pain management, represents a routine execution of the company's standing agreement to provide pharmaceutical commodities supporting U.S. military medical operations and readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/10/25 |